Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Safety and Effectiveness of the VARIPULSE™ Catheter System in the Treatment of Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein (With or Without Posterior Wall Isolation) and Superior Vena Cava Isolation: A Randomized Controlled Trial

NCT07527299 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT07527299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07527299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Safety and Effectiveness of the VARIPULSE™ Catheter System in the Treatment of Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein (With or Without Posterior Wall Isolation) and Superior Vena Cava Isolation: A Randomized Controlled Trial
Lead sponsor
Biosense Webster, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
August 26, 2026
Completion date
August 24, 2031
Enrollment
1,070 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation